Read this topic

Basic Neurosciences · Paper A

Neurotransmitter receptors

The idea

Picture the moment nicotine reaches your brain: it locks onto nicotinic acetylcholine receptors sitting on dopamine neurons in your reward pathway, those neurons fire, dopamine floods out, and that flood is what makes lighting the next cigarette feel so pulling.

Caffeine works nothing like that. It doesn't press an accelerator — it releases a brake. Adenosine is a chemical that quietly builds up through the day and makes you drowsy; caffeine blocks the adenosine receptor, the brake lifts, and the alertness you feel afterwards is your own arousal system running unheld, not a new signal caffeine put there.

Both stories teach the same lessonwhich receptor a drug binds decides everything it does, even when two drugs touch the same neurotransmitter system. You'll see this rule play out again below with glutamate, GABA and glycine — same transmitter, wildly different consequences, depending only on which receptor is listening.

How it works

Two receptor architectures explain almost everything in this card, and it helps to picture them as a fast door versus a slow phone call. An ionotropic receptor IS the door: the neurotransmitter binds and the channel it sits on swings open immediately, letting ions through in milliseconds. A metabotropic receptor works more like picking up a phone: binding doesn't open anything directly, it dials a G-protein messenger system inside the cell, and that call takes longer to deliver its message.

AMPA receptors are the fast door for glutamate: glutamate binds and an ion channel opens directly, giving a rapid excitatory signal. 5-HT1 receptors are the slow phone call for serotonin: they are metabotropic G-protein-coupled receptors, so serotonin binding starts an intracellular signalling cascade rather than snapping a channel open.

The same split explains GHB (gamma-hydroxybutyrate). GHB acts mainly at GABA-B receptors, GABA's own slow-phone-call subtype, rather than at the fast-door GABA-A receptor most sedative-hypnotics target — which is why GHB's clinical and toxic profile differs from a typical sedative even though both ultimately lean on the GABA system.

Glycine receptors are a fast door too, but for a different, purely inhibitory transmitter: glycine binding opens a chloride channel in spinal-cord neurons, damping their firing. Strychnine blocks that door. With the inhibitory brake removed, motor neurons fire unchecked, and the result is strychnine poisoning: sudden, severe, and painful muscle spasms.

How to spot it

A stem describing dopamine release in the reward pathway following a drug's binding is describing nicotinic acetylcholine receptor action, not muscarinic.
A stem describing a stimulant that blocks a receptor rather than activating one, with drowsiness lifting as a result, is describing adenosine receptor blockade (caffeine).
A stem contrasting a fast, channel-opening receptor with a slower, G-protein-coupled one for the same transmitter is describing the ionotropic-versus-metabotropic distinction (AMPA vs 5-HT1, or GABA-A vs GABA-B).
A stem describing painful, generalised muscle spasms from a poisoning is describing glycine receptor blockade by strychnine, not a GABA-receptor toxin.

Tell it apart

Nicotinic acetylcholine receptors — vs muscarinic acetylcholine receptors: nicotinic stimulation drives the dopamine release behind nicotine's reward effect; muscarinic receptors don't.
Adenosine receptors — vs direct dopamine/noradrenaline action: caffeine blocks adenosine receptors to release the drowsiness brake; it doesn't stimulate dopamine or noradrenaline directly.
AMPA receptors (fast door, ionotropic) — vs 5-HT1 receptors (slow phone call, metabotropic): the same word 'receptor' hides opposite speed and mechanism.
GABA-B receptors (metabotropic, GHB's main target) — vs GABA-A receptors (ionotropic, most sedative-hypnotics' target): same transmitter, different subtype, different drug class.
Glycine receptors (blocked by strychnine) — vs GABA receptors (blocked by other convulsant toxins): both inhibitory, but a different transmitter and a different poisoning picture.

Transmitter	Fast door (ionotropic)	Slow phone call (metabotropic)
Glutamate	AMPA — fast excitatory signal	—
Serotonin	—	5-HT1 — intracellular cascade
	GABA-A — most sedatives' target	GABA-B — GHB's target
Acetylcholine	Nicotinic — drives reward dopamine	Muscarinic — no reward role here
Glycine	Glycine receptor — blocked by strychnine	—
Adenosine	—	Adenosine receptor — blocked by caffeine

Watch for

Assuming any receptor for a given transmitter behaves the same way — GABA-A and GABA-B are different subtypes with almost opposite drug targets (most sedatives versus GHB).
Assuming nicotine's reward effect comes from raising dopamine directly — it acts one step upstream, at nicotinic receptors on the dopamine neurons themselves.
Assuming strychnine acts on GABA receptors because both toxins cause seizures — strychnine specifically blocks glycine receptors, a separate inhibitory system.

Use it again

First identify the transmitter, then ask which specific receptor subtype the stem is describing — same transmitter, different subtype, often means a different drug class entirely.
If the stem describes a channel opening directly, think ionotropic (fast door); if it describes a slower, second-messenger effect, think metabotropic (slow phone call).
If a toxin or drug seems to fit a transmitter's 'usual' receptor but the clinical picture looks unusual, check whether it is instead acting at that transmitter's other subtype (GABA-B rather than GABA-A, muscarinic rather than nicotinic).